EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

PROM2 expression is associated with endometrial carcinoma progression-related features, PI3K/AKT pathway activation and immune infiltration estimates

Weikun Zhang, Lei Shao, Chunyan Zhang, Dongyue Qi, Jinwei Xu, Wanqiu Liu

Current Proteomics · 2026-10 · 23 (5) · 100186

DOI: 10.1016/j.curpro.2026.100186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Proteomics, 2026-10. Verfasst von Weikun Zhang und 5 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prominin-2 (PROM2) is involved in the initiation and development of multiple cancers, but its role in endometrial carcinoma (EC) remains to be comprehensively characterized.

Objectives

This study aimed to investigate PROM2 expression, survival association, immune infiltration correlation, and functional effects in EC, with a particular focus on PI3K/AKT signaling, ferroptosis-related features and stemness-like properties.

Methods

Transcriptomic and clinical data from The Cancer Genome Atlas uterine corpus endometrial carcinoma (TCGA-UCEC) cohort were analyzed to determine PROM2 expression, its prognostic value, and its association with immune infiltration estimates using Kaplan-Meier (KM) analysis, Cox regression, ESTIMATE, MCPcounter, and CIBERSORT algorithms. An external Gene Expression Omnibus (GEO) cohort was additionally used to validate PROM2 expression between EC and normal endometrial tissues. Stable PROM2 knockdown and overexpression were achieved by lentiviral transduction in HEC-1A and AN3CA cells. Cell proliferation, migration, invasion, and apoptosis were evaluated by Cell Counting Kit-8 (CCK-8), wound-healing, Transwell, 5-ethynyl-2′-deoxyuridine (EdU), and Annexin V–FITC/PI flow cytometry assays. Epithelial–mesenchymal transition (EMT) markers, stemness-related features, ferroptosis-related markers, and PI3K/AKT signaling were assessed by quantitative reverse transcription polymerase chain reaction (qRT-PCR), Western blot, C11-BODIPY 581/591 staining, and sphere formation assays. The PI3K/AKT pathway was modulated using the activator 740 Y-P and the inhibitor LY294002.

Results

PROM2 was upregulated in EC tissues compared with normal endometrial tissues in TCGA-UCEC (P = 0.0016). Additional paired tumor-normal analyses using matched TCGA-UCEC samples further confirmed higher PROM2 expression in EC tissues (P = 0.014), while the external GSE56087 cohort showed a similar increasing trend (P = 0.055). PROM2 expression showed a modest association with clinical stage distribution (P = 0.036) but no clear stage-dependent increasing trend. KM analysis showed that high PROM2 expression was associated with poorer overall survival (HR = 1.91, 95% CI = 1.14–3.21; log-rank P = 0.013), whereas Cox regression did not support PROM2 as an independent prognostic factor. PROM2-high tumors were associated with altered computational immune infiltration estimates, including higher neutrophil-related signals and lower estimated CD8⁺ T-cell abundance. Functionally, PROM2 knockdown reduced CCK-8 viability by 26.97% in HEC-1A cells and 24.21% in AN3CA cells (both P < 0.0001), reduced wound closure by 77.57% (P = 0.0034) and 53.45% (P = 0.0069), respectively, and reduced invaded cell numbers by 68.01% (P = 0.0021) and 71.95% (P = 0.0007), respectively. Apoptosis increased from 4.75 ± 0.61% to 14.18 ± 1.17% in HEC-1A cells (P = 0.0011) and from 5.19 ± 0.53% to 11.99 ± 1.58% in AN3CA cells (P = 0.0110). PROM2 overexpression produced opposite trends. Furthermore, PROM2 modulation was associated with altered phosphorylation of PI3K and AKT, and pharmacological modulation of PI3K/AKT partially reversed PROM2-associated phenotypes.

Conclusion

PROM2 expression was elevated in EC and was associated with poorer overall survival and altered computational immune infiltration estimates. In vitro PROM2-associated phenotypes were linked to PI3K/AKT pathway activity, ferroptosis-related lipid peroxidation and stemness-like properties. PROM2 should therefore be regarded as a candidate molecule associated with EC progression-related features rather than an established independent prognostic biomarker or validated therapeutic target.

Zitieren

APA

Zhang, W., Shao, L., Zhang, C., Qi, D., Xu, J., & Liu, W. (2026). PROM2 expression is associated with endometrial carcinoma progression-related features, PI3K/AKT pathway activation and immune infiltration estimates. Current Proteomics, 23(5), 100186. https://doi.org/10.1016/j.curpro.2026.100186

Vancouver

Zhang W, Shao L, Zhang C, Qi D, Xu J, Liu W. PROM2 expression is associated with endometrial carcinoma progression-related features, PI3K/AKT pathway activation and immune infiltration estimates. Current Proteomics. 2026;23(5):100186. doi:10.1016/j.curpro.2026.100186

BibTeX
@article{Zhang2026,
  author = {Zhang, Weikun and Shao, Lei and Zhang, Chunyan and Qi, Dongyue and Xu, Jinwei and Liu, Wanqiu},
  title = {PROM2 expression is associated with endometrial carcinoma progression-related features, PI3K/AKT pathway activation and immune infiltration estimates},
  journal = {Current Proteomics},
  year = {2026},
  volume = {23},
  number = {5},
  pages = {100186},
  doi = {10.1016/j.curpro.2026.100186}
}
Kostenlos starten →